ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND)

This study is ongoing, but not recruiting participants.

Sponsors and Collaborators: Centers for Disease Control and Prevention
Children's Research Triangle
Information provided by: Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier: NCT00164346
  Purpose

Children will receive comprehensive evaluations through the Children's Research Triangle (CRT) clinical program. The assessment for the child will be in accordance with the protocol developed by Astley and Clarren as performed by one of the clinic pediatricians and final diagnosis will be according to Institute of Medicine (IOM) criteria. Children will be randomized into either a Treatment or Control group. The Treatment group will receive (in addition to standard referrals) neurocognitive habilitation and psychotherapy services as well as parent psychoeducation. The Control group will be referred for intervention through existing community and school-based agencies.


Condition Intervention Phase
Fetal Alcohol Syndrome
Alcohol-Related Neurodevelopmental Disorder
Behavioral: neurocognitive habilitation
Phase I
Phase II

MedlinePlus related topics:   Fetal Alcohol Syndrome   

Drug Information available for:   Ethanol   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Other, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study
Official Title:   Neurocognitive Habilitation for Children With FAS/ARND

Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:
  • foster care placement stability

Estimated Enrollment:   100
Study Start Date:   January 2002
Estimated Study Completion Date:   December 2009

Detailed Description:

Neurocognitive habilitation, based on the traumatic brain injury literature for teaching compensatory skills, will be the primary intervention. Interventions will be individually designed and delivered through individual therapy sessions. Audiotapes will augment the sessions to facilitate implementation of strategies in the home environment. Didactic therapy will be used to foster appropriate interactions and relationships between parent and child. Children will participate in 8-week group sessions that will include neurocognitive exercises, homework sessions, and possibly group psychotherapy. An educational specialist will provide school and legal advocacy services as well as observations of the child in the classroom that could lead to educational modifications.

Parent Component: Family education programs and parent support groups using psychoeducational approaches will be the means of intervening with parent behaviors. Parents will be instructed on becoming advocates for their child. Groups of 8 to 12 parents will meet for one 2-hour session per week for 8 weeks. Each session will include:

  1. neurocognitive exercises (relaxation);
  2. specific topic discussions; and
  3. general support.

During the last hour of the final two weeks of the program, parent and children will be combined to practice learned techniques. Children and parents will participate in monthly "booster" sessions.

Evaluation Plan: Treatment and control groups will be compared using pre- and post-test measures. Post-tests will be at the conclusion of the intervention, as well as at 12, and 24-month follow-ups. Process and outcome measures will be evaluated.

  Eligibility
Ages Eligible for Study:   6 Years to 12 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Children aged 6 to 12 years
  • Children in the care of Illinois foster care
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00164346

Locations
United States, Illinois
Children's Research Triangle    
      Chicago, Illinois, United States, 60601

Sponsors and Collaborators
Centers for Disease Control and Prevention
Children's Research Triangle

Investigators
Principal Investigator:     Ira Chasnoff, MD     Children's Research Triangle    
  More Information


Study ID Numbers:   CDC-NCBDDD-3710, U84/CCU520164-01
First Received:   September 9, 2005
Last Updated:   September 20, 2007
ClinicalTrials.gov Identifier:   NCT00164346
Health Authority:   United States: Federal Government

Keywords provided by Centers for Disease Control and Prevention:
fetal alcohol syndrome (FAS)  
alcohol-related neurodevelopmental disorder (ARND)  

Study placed in the following topic categories:
Alcohol-Induced Disorders
Fetal Diseases
Fetal Alcohol Syndrome
Pregnancy Complications
Fetal alcohol syndrome
Substance-Related Disorders
Disorders of Environmental Origin
Alcohol-Related Disorders
Ethanol

Additional relevant MeSH terms:
Pathologic Processes
Disease
Syndrome

ClinicalTrials.gov processed this record on October 24, 2008




Links to all studies - primarily for crawlers